Reliance Global Group Stock (NASDAQ: RELIW)

Reliance Global Group Stock (NASDAQ:RELIW), Trade Ideas

Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing an acquisition strategy, initially and primarily focused on wholesale and retail insurance agencies. Its primary strategy is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.

Marpai Partners With Oshi Health To Offer The Most Clinically Advanced Virtual Digestive Care To Its Employer Health Plan Members

News

Penny Stocks

Tech

MMMM

MRAI

RELIW

Marpai, Inc. (NASDAQ: MRAI), an artificial intelligence (AI)-powered Third-Party Administrator (TPA), has partnered with Oshi Health, In

Reliance Global Group, Inc. - Series A Warrants

Reliance Global Group Inc

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a <a href="https://www.benzinga.com/yield-investments">high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.
<h3 class="wp-block-heading">Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>)</h3>
<ul>
<li>Dividend Yield: 6.40%</li>
<li>Guggenheim analyst Vamil Divan initiated coverage on the stock with a Buy rating and a price target of $36 on Feb. 23, 2024. This analyst has an accuracy rate of 76%.</li>
<li>TD Cowen analyst Steve Scala downgraded the stock from Outperform to Market Perform with a price target of $32 on Jan. 4, 2024. This analyst has an accuracy rate of 73%.</li>
<li>Recent News: On April 24, Pfizer's board of directors declared a 42 cents second-quarter 2024 dividend on the company&#8217;s common stock.</li>
</ul>
<h3 class="wp-block-heading">Gilead Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>)</h3>
<ul>
<li>Dividend Yield: 4.59%</li>
<li>Wells Fargo analyst Mohit Bansal maintained an Equal-Weight rating and cut the price target from $84 to $78 on March 4, 2024. This analyst has an accuracy rate of 76%.</li>
<li>RBC Capital analyst Brian Abrahams maintained a Sector Perform rating and slashed the price target from $76 to $75 on Feb. 14, 2024. This analyst has an accuracy rate of 62%.</li>
<li>Recent News: Gilead Sciences is expected to release first quarter 2024 financial results on Thursday, April 25.</li>
</ul>
<h3 class="wp-block-heading">Patterson Companies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDCO#NASDAQ">PDCO</a>)</h3>
<ul>
<li>Dividend Yield: 3.97%</li>
<li>Morgan Stanley analyst Erin Wright maintained an Equal-Weight rating and cut the price target from $38 to $35 on Nov. 30, 2023. This analyst has an accuracy rate of 77%.</li>
<li>Stifel analyst Jonathan Block reiterated a Hold rating with a price target of $32 on Nov. 28, 2023. This analyst has an accuracy rate of 76%.</li>
<li>Recent News: On March 11, Patterson Companies approved a $500 million stock buyback and declared a quarterly dividend of 26 cents per share.</li>
</ul>
Read More: <a href="https://www.benzinga.com/news/24/04/38402061/jim-cramer-says-this-energy-stock-is-terrific-calls-caseys-general-stores-a-winner">Jim Cramer Says This Energy Stock Is &#8216;Terrific,&#8217; Calls Casey&#8217;s General Stores A &#8216;Winner&#8217;</a>

Dividends

Price Target

Pre-Market Outlook

Markets

Trading Ideas

GILD

PDCO

Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields

WIIM

ENCOR Group shares are trading higher after the company reported better-than-expected Q1 financial results and increase FY24 guidance above estimates.

HC Wainwright &amp; Co. analyst Andrew Fein maintains Biogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) with a Buy and lowers the price target from $325 to $300.

Analyst Ratings

BIIB

HC Wainwright & Co. Maintains Buy on Biogen, Lowers Price Target to $300

Rosenblatt analyst Barton Crockett maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Buy and raises the price target from $520 to $562.

Rosenblatt Maintains Buy on Meta Platforms, Raises Price Target to $562

Market-Moving Exclusives

Exclusives

VRAX

EXCLUSIVE: Virax Biolabs Tells Benzinga 'The launch marks a significant milestone for Virax as it brings us a step closer to commercializing ViraxImmuneTM  as a full In-Vitro-Diagnostic product'

Darling Ingredients (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.46 by 8.7 percent. This is a 56.14 percent decrease over earnings of $1.14 per share from the same period last year. The company reported quarterly sales of $1.420 billion which missed the analyst consensus estimate of $1.484 billion by 4.26 percent. This is a 20.71 percent decrease over sales of $1.791 billion the same period last year.

Earnings

Earnings Beats

Earnings Misses

Darling Ingredients Q1 2024 GAAP EPS $0.50 Beats $0.46 Estimate, Sales $1.420B Miss $1.484B Estimate

Brunswick shares are trading lower following Q1 financial results and roughly in-line guidance.

EXCLUSIVE: Virax Biolabs Tells Benzinga Co. Launches Portfolio Of Immune Profiling Solutions Evaluating Adaptive Immunity In Post-Viral Syndromes

ConnectOne Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNOB#NASDAQ">CNOB</a>) reported quarterly earnings of $0.41 per share which missed the analyst consensus estimate of $0.42 by 2.38 percent. This is a 30.51 percent decrease over earnings of $0.59 per share from the same period last year. The company reported quarterly sales of $60.300 million which missed the analyst consensus estimate of $61.598 million by 2.11 percent. This is a 10.11 percent decrease over sales of $67.084 million the same period last year.

CNOB

ConnectOne Bancorp Q1 2024 GAAP EPS $0.41 Misses $0.42 Estimate, Sales $60.300M Miss $61.598M Estimate

BlackRock&#8216;s iShares Bitcoin Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>) has seen its <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38401088/bitcoin-spot-etfs-net-31-6m-inflows-as-hong-kong-readies-for-etf-launches">record-breaking streak of inflows</a> come to an end on Wednesday. 
What Happened: According to <a href="https://sosovalue.xyz/assets/etf">data </a>from SoSoValue, IBIT recorded no net inflows for the day, snapping a 71-day stretch of continuous investment. 
On Wednesday, spot Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) ETF flows saw net outflows totaling $121 million, signaling a turbulent day for cryptocurrency investments.
Notably, Grayscale's Bitcoin Trust ETF (GBTC) registered the most substantial single-day outflow, withdrawing $130 million. 
Contrasting this, Fidelity Wise&#8217;s Origin Bitcoin Fund (BATS:<a class="ticker" href="https://www.benzinga.com/stock/FBTC#BATS">FBTC</a>) emerged as the frontrunner for inflows, attracting $5.61 million in a single day, followed closely by the collaborative ETF from Ark Invest and 21Shares (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKB#BATS">ARKB</a>), which saw an influx of $4.17 million.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/27091545/Benzinga-conference.gif" alt="Benzinga future of digital assets conference" class="wp-image-267246" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38413962/jack-dorsey-wants-to-make-bitcoin-mining-as-easy-as-plugging-in-a-lamp-heres-how">Jack Dorsey Wants To Make Bitcoin Mining As Easy As Plugging In A Lamp: Here&#8217;s How</a>
Hong Kong Steps Into The Crypto ETF Arena
The news of BlackRock&#8217;s pause coincides with a significant development in the Asian market. 
HashKey Exchange announced the completion of the first-ever cryptocurrency subscription for Bitcoin and Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) spot ETFs offered by Hong Kong-based Bosera International and HashKey Capital. 
This subscription model allows for redemption without immediate sale of the underlying assets, potentially offering cost and liquidity benefits to investors.
Hong Kong&#8217;s foray into cryptocurrency ETFs marks a potential turning point for the Asian market. 
These ETFs are expected to begin trading on the Hong Kong Stock Exchange on April 30, providing investors in the region with a new avenue for cryptocurrency exposure.
What&#8217;s Next: The Benzinga <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> event, scheduled for Nov. 19, will convene industry leaders, analysts, and investors to discuss these critical developments. 
This conference presents a unique opportunity to gain insights into the future of Bitcoin ETFs, cryptocurrency subscriptions, and the broader digital asset ecosystem. 
Don&#8217;t miss out on this chance to stay ahead of the curve in this <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38412858/trumps-crypto-portfolio-rebounds-with-1m-weekly-profit-which-crazy-new-currencies-does-he-">rapidly changing market.</a>
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38408395/why-is-mog-crypto-coin-going-up-trader-sees-billions-as-price-target">Why Is MOG Crypto Coin Going Up? Trader Sees &#8216;Billions&#8217; As Price Target</a>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

ARK 21Shares Bitcoin ETF ARK 21Shares Bitcoin ETF

ARKB

Fidelity Wise Origin Bitcoin Fund Fidelity Wise Origin Bitcoin Fund

FBTC

IBIT

BlackRock's Spot Bitcoin ETF Sees Zero Inflows, As Net Outflows Tally $130M On Wednesday

Jason Tsai, currently VP of IR and Finance at Silicon Motion, has been appointed Interim Chief Financial Officer of the Company effective as of April 25, 2024.&nbsp;

Management

SIMO

Silicon Motion Says Riyadh Lai Will Be Stepping Down As CFO, Effective April 25, 2024; Jason Tsai Named As Interim CFO

Craig-Hallum analyst Jeremy Hamblin initiates coverage on Red Robin Gourmet Burgers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRGB#NASDAQ">RRGB</a>) with a Buy rating and announces Price Target of $20.

Initiation

RRGB

Craig-Hallum Initiates Coverage On Red Robin Gourmet Burgers with Buy Rating, Announces Price Target of $20

CARR

Carrier Global shares are trading higher, rebounding from earlier weakness following Q1 earnings.

Latest version enhances operational efficiency, regulatory reporting, and strategic decision-making with robust business insights

General

SPNS

Sapiens Unveils Enhanced Reinsurance and Analytics Solution Catering to Evolving Market Demands

California Water Servs Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWT#NYSE">CWT</a>) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $0.36 by 236.11 percent. This is a 402.5 percent increase over losses of $(0.40) per share from the same period last year. The company reported quarterly sales of $270.75 million which beat the analyst consensus estimate of $183.85 million by 47.27 percent. This is a 106.52 percent increase over sales of $131.10 million the same period last year.

California Water Servs Gr Q1 EPS $1.21 Beats $0.36 Estimate, Sales $270.75M Beat $183.85M Estimate

Commodities

LODE

Comstock Completed The Commissioning Stages Of Its Demonstration-scale Production Facility In Silver Springs, Nevada

Buybacks

Union Pacific Says Restarting Share Repurchases In Q2

Union Pacific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNP#NYSE">UNP</a>) reported quarterly earnings of $2.69 per share which beat the analyst consensus estimate of $2.52 by 6.75 percent. The company reported quarterly sales of $6.00 billion which beat the analyst consensus estimate of $5.98 billion by 0.26 percent. This is a 0.92 percent decrease over sales of $6.06 billion the same period last year.

Union Pacific Q1 2024 Adj EPS $2.69 Beats $2.52 Estimate, Sales $6.00B Beat $5.98B Estimate

ULBI

Ultralife shares are trading higher after the company reported better-than-expected Q1 financial results.

2024 Full Year&nbsp;Guidance:
The Company reaffirms its FY 2024&nbsp;outlook&nbsp;for net sales of&nbsp;$3.42 billion&nbsp;to&nbsp;$3.58 billion, adjusted sales of&nbsp;$3.40 billion&nbsp;to&nbsp;$3.55 billion, net earnings and margin of&nbsp;$125 million&nbsp;to&nbsp;$160 million&nbsp;and&nbsp;3.7%&nbsp;to&nbsp;4.5%, respectively, adjusted EBITDA of&nbsp;$470 million&nbsp;to&nbsp;$510 million, and adjusted EBITDA margin of&nbsp;13.8%&nbsp;to&nbsp;14.4%. PHINIA expects to generate&nbsp;$160 million&nbsp;to&nbsp;$200 million&nbsp;in adjusted free cash flow. Adjusted tax rate is expected to be in the range of&nbsp;28%&nbsp;to&nbsp;32%.

Guidance

PHIN

PHINIA Reaffirms 2024 Outlook For Net Sales Of $3.42B-$3.58B, Adjusted Sales Of $3.40B-$3.55B Vs. $3.48B Consensus; Expects To Generate $160M-$200M In Adjusted Free Cash Flow

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start Tuesday trading with a breakdown of the biggest pre-market stock movers worth watching this morning!



Moving stocks this morning are collaboration agreements, merger plans, earnings, public share offerings and more.



Let&rsquo;s get into that news down below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Tracon Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/tcon-stock-quote/">TCON</a>) stock is rocketing more than 54% with heavy trading after announcing a <a href="https://www.nasdaq.com/market-activity/stocks/tcon/press-releases">product development platform agreement</a>.</li>



<li>LQR House (NASDAQ:<a href="https://investorplace.com/stock-quotes/lqr-stock-quote/">LQR</a>) shares are soaring over 46% after <a href="https://www.nasdaq.com/press-release/lqr-house-repurchases-1476355-shares-in-ongoing-share-buy-back-initiative-2023-11-20">revealing share repurchase data</a>. </li>



<li>Mountain Crest Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/mcaf-stock-quote/">MCAF</a>) stock is surging close to 43% as it <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317880079&amp;type=PDF&amp;symbol=MCAF&amp;cdn=72ab37bf3b408f565581d0c0c65a6ea6&amp;companyName=Mountain+Crest+Acquisition+Corp.+IV&amp;formType=425&amp;formDescription=Prospectuses+and+communications%2C+business+combinations&amp;dateFiled=2023-11-20">moves forward with merger plans</a>.</li>



<li>Connect Biopharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/cntb-stock-quote/">CNTB</a>) shares are gaining more than 26% after announcing an <a href="https://www.nasdaq.com/press-release/connect-biopharma-and-simcere-announce-exclusive-licensing-and-collaboration">exclusive licensing and collaboration agreement</a>.</li>



<li>Symbotic (NASDAQ:<a href="https://investorplace.com/stock-quotes/sym-stock-quote/">SYM</a>) stock is increasing over 22% alongside a <a href="https://finance.yahoo.com/news/symbotic-reports-2023-results-record-210000758.html">strong Q4 earnings report</a>.</li>



<li>Marpai (NASDAQ:<a href="https://investorplace.com/stock-quotes/mrai-stock-quote/">MRAI</a>) shares are climbing more than 19% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317879635&amp;type=PDF&amp;symbol=MRAI&amp;cdn=93528add0cd2688d706c15aa396522f1&amp;companyName=Marpai+Inc.&amp;formType=4&amp;formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&amp;dateFiled=2023-11-20">with insider buying</a>.</li>



<li>Invo Bioscience (NASDAQ:<a href="https://investorplace.com/stock-quotes/invo-stock-quote/">INVO</a>) stock is rising over 19% after announcing a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317880292&amp;type=PDF&amp;symbol=INVO&amp;cdn=e17d8040a594797e299f47c01eef3054&amp;companyName=INVO+BioScience+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2023-11-20">share exchange agreement</a>.</li>



<li>Mobiv Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/mobv-stock-quote/">MOBV</a>) shares are jumping more than 14% on Tuesday morning.</li>



<li>Renalytix (NASDAQ:<a href="https://investorplace.com/stock-quotes/rnlx-stock-quote/">RNLX</a>) stock is getting an over 12% boost without any clear news.</li>



<li>Artivion (NYSE:<a href="https://investorplace.com/stock-quotes/aort-stock-quote/">AORT</a>) shares are up more than 11% on Tuesday.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Reliance Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/reli-stock-quote/">RELI</a>) stock is plummeting over 39% after announcing a <a href="https://www.nasdaq.com/press-release/reliance-global-group-inc.-announces-proposed-underwritten-public-offering-2023-11-20">proposed public share offering</a>.</li>



<li>MorphoSys (NASDAQ:<a href="https://investorplace.com/stock-quotes/mor-stock-quote/">MOR</a>) shares are diving nearly 25% alongside <a href="https://www.nasdaq.com/press-release/ad-hoc%3a-morphosys-phase-3-study-of-pelabresib-in-myelofibrosis-demonstrates">Phase 3 study results</a>.</li>



<li>Sibanye Stillwater (NYSE:<a href="https://investorplace.com/stock-quotes/sbsw-stock-quote/">SBSW</a>) stock is tumbling more than 23% on <a href="https://www.bloomberg.com/news/articles/2023-11-21/sibanye-loses-824-million-of-value-on-convertible-bond-sale">a convertible bond sale</a>.</li>



<li>Alzamend Neuro (NASDAQ:<a href="https://investorplace.com/stock-quotes/alzn-stock-quote/">ALZN</a>) shares are taking an almost 21% beating on Tuesday.</li>



<li>Nogin (NASDAQ:<a href="https://investorplace.com/stock-quotes/nogn-stock-quote/">NOGN</a>) stock is dropping close to 20% after a roughly 74% rally yesterday. </li>



<li>Galmed Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/glmd-stock-quote/">GLMD</a>) shares are sliding nearly 19% after <a href="https://www.nasdaq.com/press-release/galmed-announces-a-delay-in-the-initiation-of-its-primary-sclerosing-cholangitis-psc">announcing a clinical trial delay</a>.</li>



<li>AgileThought (NASDAQ:<a href="https://investorplace.com/stock-quotes/agil-stock-quote/">AGIL</a>) stock is decreasing over 18% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317880221&amp;type=PDF&amp;symbol=AGIL&amp;cdn=9c2c8a730197e2b274fa81420856dd5c&amp;companyName=AgileThought+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2023-11-20">a delisting notice</a>.</li>



<li>Bruush Oral Care (NASDAQ:<a href="https://investorplace.com/stock-quotes/brsh-stock-quote/">BRSH</a>) shares are falling more than 13% <a href="https://investorplace.com/2023/11/why-is-bruush-oral-care-brsh-stock-up-184-today/">after a rally yesterday</a>.</li>



<li>Vicarious Surgical (NYSE:<a href="https://investorplace.com/stock-quotes/rbot-stock-quote/">RBOT</a>) stock is slipping almost 13% on Tuesday morning.</li>



<li>Acutus Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/afib-stock-quote/">AFIB</a>) shares close out our pre-market stock movers down over 12% on Tuesday.</li>
</ol>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771234">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771244">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT771242">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2023/11/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-nov-21st/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

AFIB

AGIL

ALZN

AORT

BRSH

CNTB

GLMD

INVO

MCAF

MOBV

NOGN

RBOT

RNLX

SBSW

Press Releases

Reliance Global Group Announces Letter of Intent for Most Significant Acquisition to Date

New to The Street Announces Five Corporate Interviews, Episode 535, Airing on the FOX Business Network on Monday, December 4, 2023, at 10:30 PM PT

New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT

New to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10:30 PM PT

Reliance Global Group Provides Year-End Update on RELI Exchange

New to The Street Airs on the FOX Business Network, Episode 550, Featuring Six Corporate Interviews, Broadcast Monday, January 22, 2024, at 10:30 PM PT

RELI Exchange Launches the Client Referral Portal into its Proprietary InsurTech Platform

Reliance Global Group Schedules Fourth Quarter 2023 Financial Results and Business Update Conference Call

Reliance Global Group's Revenue Grows by 17% and 40% in 2023 Compared to 2022 and 2021, respectively

New to The Street TV Announces its Next Two Shows Broadcastings with Five Business Guest Interviews, Episode 566 Airs on Bloomberg TV as A Sponsored Programming Tonight, Thursday, April 4, 2024, at 9:30 PM PT, and Episode 567 Airs on The FOX Business Network, Monday, April 8, 2024, at 10:30 PM PT

ACVF

ACXP

BEGI

BTDR

CSE:MWRK

CSE:SKUR

MWRK

PETV

PETVW

RELI

SGTM

SWISF

Abacus Life

Arthur J. Gallagher

Aon plc Class A Ordinary Shares (Ireland)

Brown & Brown

BRP Group

Cheche Group Inc. - Class A Ordinary Shares

Cheche Group

Crawford & Company Common Stock

eHealth

Fanhua Inc. - American depositary shares, each representing 20 ordinary shares

Fanhua

GoHealth

Goosehead Insurance, Inc. - Class A Common Stock

Goosehead Insurance

Hagerty

Hippo Holdings

Huize Holding Limited - American Depositary Shares

Huize Holding

Marsh & McLennan Companies, Inc. Common Stock

Marsh & McLennan

Marpai

Reliance Global Group, Inc. - Common Stock

Reliance Global Group

Ryan Specialty Holdings, Inc. Class A Common Stock

Ryan Specialty Hldgs

SelectQuote

Waterdrop Inc. American Depositary Shares (each representing the right to receive 10 Class A Ordinary Shares)